As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  4/1/24  Emmaus Life Sciences, Inc.        NT 10-K    12/31/23    1:21K                                    EdgarAgents LLC/FA       
 2/29/24  Lee Willis C                      4          Dir.,Off.²  1:9K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
 2/26/24  Emmaus Life Sciences, Inc.        8-K:1,2,3,9 2/21/24   13:431K                                   EdgarAgents LLC/FA       
  2/5/24  Zwicker Ian Harvey                4          Director²   1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  ZEN Wei Peu                       4          Director²   1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  Lim Seah H.                       4          Director²   1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  Stark Charles William             4          Officer²    1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  Sekulich George                   4          Dir.,Off.²  1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  Nagasaki Yasushi                  4          Officer²    1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  2/5/24  Lee Willis C                      4          Dir.,Off.²  1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
  1/3/24  Lee Willis C                      4/A        Dir.,Off.²  1:11K  Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
12/22/23‡ Lim Seah H.                       SC 13G                 1:42K  Emmaus Life Sciences, Inc.        EdgarAgents LLC/FA       
12/21/23  Lim Seah H.                       4          Director²   1:4K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
12/20/23  Lim Seah H.                       3/A        Director²   1:5K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
12/19/23  Lim Seah H.                       4          Director²   1:12K  Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
12/19/23  ZEN Wei Peu                       4          Director²   1:7K   Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
12/20/23‡ Emmaus Life Sciences, Inc.        8-K:1,3,9  12/15/23   11:217K                                   EdgarAgents LLC/FA       
 12/4/23  Lee Willis C                      4          Dir.,Off.²  1:11K  Emmaus Life Sciences, Inc.        DONNELLEY FIN… File16/FA 
11/14/23  Emmaus Life Sciences, Inc.        8-K:2,9    11/14/23   11:240K                                   EdgarAgents LLC/FA       
11/14/23‡ Emmaus Life Sciences, Inc.        10-Q        9/30/23   80:17M                                    Donnelley … Solutions/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.